> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bill Introduced to Reduce Animal Testing
- URL: https://www.fdaweb.com/bill-introduced-to-reduce-animal-testing/
- Published: 2020-11-16T12:00:00.000Z
- Updated: 2026-09-14T16:36:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148095

Representatives **Brendan Boyle** (D-PA), **Scott Perry** (R-PA) and **Madeleine Dean** (D-PA) have introduced the Alternatives to Animals for Regulatory Fairness (AARF) Act to modernize the drug approval process. “The AARF Act ensures that pharmaceutical companies are allowed to use high-tech and humane alternatives to outdated testing on dogs and other animals to fulfill Food and Drug Administration (FDA) regulatory requirements,” they said in a [news release](https://boyle.house.gov/media-center/press-releases/boyle-perry-dean-introduce-animal-testing-alternatives-legislation?ref=fdaweb.com).  

"Science has come a long way and there are now better ways to assess the safety of drugs than conducting deadly experiments on puppies,” said congressman Boyle. “Current law fails to account for newer, modern approaches to drug development that do not involve testing on dogs or other animals,” he said.

More effective and humane alternatives are available, including organs-on-chips technology being developed by researchers at the University of Pennsylvania, the release said. “A June 2020 national poll of 1,000 Americans conducted by Lincoln Park Strategies found that two-thirds of respondents want the FDA to allow drug companies to use modern alternatives to animal tests,” it said. “Currently, the FDA requires companies to subject thousands of dogs and other animals each year to painful and inaccurate drug safety tests, even though government scientists acknowledge that over 90% of drugs that pass these animal tests fail in humans because they’re ineffective or harmful.”